Skip to Content

Lesinurad Pregnancy and Breastfeeding Warnings

Lesinurad is also known as: Zurampic

Lesinurad Pregnancy Warnings

Safety has not been established during pregnancy. US FDA pregnancy category: Not assigned. Risk Summary: No available human data on use of this drug in pregnant women to inform a drug-related risk. Comments: In female patients using hormonal contraceptives to prevent pregnancy, concomitant use with this drug may decrease contraceptive reliability; use of adequate methods of non-hormonal contraception should be discussed.

Studies in rabbits and rats have failed to reveal evidence of teratogenicity, effect on fetal development, or survival at doses of 10 times the maximum recommended human dose (MRHD) and 45 times MRHD, respectively; however, maternal toxicity was observed. There are no controlled data in human pregnancy. US FDA pregnancy category Not assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion about the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Lesinurad Breastfeeding Warnings

No information exists regarding excretion or effect on milk production in humans. In rats dosed at levels approximately 5 times the maximum recommended human dose from gestation day 7 to lactation day 20, this drug did not affect growth and development of offspring; concentrations in the mothers' plasma and milk were approximately equal.

Safety has not been established. Excreted into human milk: Unknown Excreted into animal milk: Yes Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Zurampic (lesinurad)." Astra-Zeneca Pharmaceuticals, Wilmington, DE.

References for breastfeeding information

  1. "Product Information. Zurampic (lesinurad)." Astra-Zeneca Pharmaceuticals, Wilmington, DE.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide